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Chronic kidney disease in sub-Saharan Africa
Infectious diseases—led by HIV/AIDS, tuberculosis, 
and malaria—are still the leading cause of death in 
sub-Saharan Africa; however, the contribution of non-
communicable diseases to morbidity and mortality 
in the region has grown over the past 30 years. These 
emerging non-communicable diseases in Africa have 
been attributed at least in part to the improving 
longevity, urbanisation, and modernisation of cultures 
in the region. Cardiometabolic diseases have been 
suggested to be the leading contributor to deaths 
due to non-communicable diseases in sub-Saharan 
Africa,1 with high and rapidly increasing incidences of 
these cardiometabolic diseases reported across diverse 
settings in the region. For instance, the International 
Diabetes Federation projects that Africa is set to witness 
the highest relative increase in diabetes, by 156% 
between 2017 and 2045, with the total population 
of adults with diabetes increasing from 16 million to 
41 million people.2 Populations in sub-Saharan Africa 
have also been shown to have a high prevalence of 
hypertension (48%) and obesity (20%).3 To this list we 
can now add chronic kidney disease, as shown by Jaya 
George and colleagues in The Lancet Global Health.4
In a cross-sectional population study, that involved 
over 8000 participants aged 40–60 years at six centres 
from four African countries, the overall prevalence of 
chronic kidney disease was reported as 10·7% (95% CI 
9·9–11·7).4 The study by George and colleagues supports 
the results of a 2018 meta-analysis that examined 
98 432 individuals from 98 studies in Africa and 
reported an overall prevalence of chronic kidney disease 
stages 1–5 of 15·8% (95% CI 12·1–19·9) and a prevalence 
of chronic kidney disease stages 3–5 of 4·6% (3·3–6·1) 
for in the general population.5 Given the increasing 
incidence of hypertension, HIV, and diabetes in Africa, 
all of which were independently associated with chronic 
kidney disease in the study by George and colleagues, 
the stage is set for a major disruption in health provision 
that would demand major infrastructural changes 
and a hefty increase in health budgets if efforts are 
not immediately made to prevent the onset of chronic 
kidney disease.
The significantly different prevalences in chronic 
kidney disease between the four subregions analysed is 
a clear indication of the different transition stages across 
participating countries. Prevention measures that have 
been put in place for HIV/AIDS, although not optimal, 
might be of use to halt the advancing prevalence of 
non-communicable diseases in Africa. In this regard, 
similar to campaigns in east and southern Africa aiming 
for individuals to find out their HIV status, individuals 
could be encouraged to find out their diabetes and 
hypertension status, which are strong determinants 
of chronic kidney disease. Renal registries might also 
be useful for establishing the causes of chronic kidney 
disease and end-stage renal disease. The establishment 
of an Africa Renal Registry in 2015 by the African 
Association of Nephrology and the African Paediatric 
Nephrology Association could provide further data that 
might assist various health organisations in Africa to 
plan effective strategies.6
Estimated glomerular filtration rate (eGFR) is 
considered the best overall index of kidney function 
and standardisation of creatinine measurements, a 
key component of calculating the eGFR, is crucial in 
identifying and stratifying patients accurately. In George 
and colleagues’ study,4 creatinine measurements were 
done in one central laboratory using an isotope dilution 
mass spectrometry (IDMS)-traceable method; however, 
many laboratories in Africa are not using methods for 
creatinine that are IDMS-traceable. Africa in general 
faces huge challenges, with shortages of qualified 
personnel and quality of laboratory tests. According 
to the latest figures published by the African Society 
for Laboratory Medicine, few laboratories outside 
South Africa have been accredited to internationally 
recognised standards. Point-of-care measurement of 
creatinine is an attractive alternative to measuring 
creatinine in traditional laboratories. Point-of-care 
testing has been shown to be effective in diagnosing 
and monitoring of patients with HIV and tuberculosis 
in South Africa.7 With improvements in point-of-care 
testing technology and improved connectivity, such 
testing for creatinine can easily be introduced as part of 
a concerted effort to meet the quadruple burden of HIV, 
tuberculosis, diabetes, and chronic kidney disease.
Of greater importance is that the four-variable 
Modification of Diet in Renal Disease (4-v MDRD) and 
Chronic Kidney Disease Epidemiology Collaboration 
(CKD-EPI) equations used by George and colleagues 
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have previously been shown to perform better without 
adjustments for African American ethnicity and are 
inaccurate for populations in South Africa, Kenya, and 
Ghana.8–10 Therefore, until these equations are validated 
in Africa, the accuracy of the findings of this Article 
and any other studies in Africa is unknown. These 
limitations have obvious public health implications 
for the implementation of large-scale screening and 
programmes for the prevention and management of 
chronic kidney disease.
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